SANUWAVE Health, Inc. (SNWV)

NASDAQ: SNWV · USD

$5.93

+0.08 (+1.4%)· Recorded snapshot

Market cap	51M
Revenue (ttm)	44M
Net income (ttm)	15.3M
EPS (ttm)	$0.78
Shares out	8.6M
P/E (trailing)	7.6x
Volume	36,204.3
Beta	1.42

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 44M
Net income (ttm): 15.3M
EPS (ttm): $0.78
P/E (trailing): 7.6x
Market cap: 51M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Giữ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/E7.6

P25 15.4P50 25.8P75 43.5

ROEn/a

P25 -113.8P50 -46.5P75 -0.9

ROIC22.3

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All SNWV indicators

Market & fundamental data

Available fields

239

Groups with data

Currency

USD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001417663
Company name	SANUWAVE Health, Inc.
Country	United States
Country code	US
CUSIP number	80303D305
Earnings date	2026-08-06
Earnings time	amc
Employees	55
Employees change	9
Employees growth	19.57%
Enterprise value	$62.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2004
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US80303D3052
Last 10-K release date	2026-03-26
Last earnings date	2026-08-06
Last refreshed	2026-11-04
Last stock split date	2024-10-18
Last stock split type	Reverse
Market cap	$51M
Market cap category	Micro-Cap
Next earnings date	2027-08-05
Options	No
Price	$5.93
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-11-03
Symbol	SNWV
U.S. state	Minnesota
Website	https://sanuwave.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	13.18%
EV/Earnings	4.09x
EV/EBIT	20.31x
EV/EBITDA	14.63x
EV/FCF	14.81x
EV/Sales	1.42x
FCF / EV yield	6.75%
FCF yield	8.25%
Forward EV/Sales	2.06x
Forward P/S	1.69x
Graham number	2.38736
Graham upside	-59.74%
Industry forward P/E	20.34x
Industry P/E	39.98x
P/B ratio	18.3x
P/E ratio	7.58x
P/FCF ratio	12.12x
P/OCF ratio	9.77x
P/S ratio	1.16x
Price/EBITDA ratio	11.97x
Sector forward P/E	24x
Sector P/E	49.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	6.97%
EBITDA margin	9.68%
Effective tax rate	0.6%
FCF margin	9.56%
Gross margin	76.33%
Operating margin	6.97%
Pretax margin	34.87%
Profit margin	34.66%
Profit per employee	$277,436
Profitable years	1
Revenue per employee	$800,400
ROA	5.51%
ROA (5Y)	-9.63%
ROCE	16.65%
ROIC	22.32%
SBC / revenue	13.37%
Tax / revenue	0.21%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	2
FCF growth (QoQ)	-60.39%
Gross profit growth	10.78%
Gross profit growth (Q)	-5.4%
Gross profit growth 3Y	36.18%
Gross profit growth 5Y	42.13%
Net income growth years	1
OCF growth	248.37%
OCF growth (Q)	-57.2%
OCF growth (QoQ)	7.05%
Operating income growth	-52.89%
Revenue growth	12.67%
Revenue growth (Q)	-3.13%
Revenue growth (QoQ)	1.25%
Revenue growth 10Y	46.18%
Revenue growth 3Y	34.44%
Revenue growth 5Y	37.83%
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1M
Depreciation and amortization	$1.2M
EBIT	$3.1M
EBITDA	$4.3M
EPS	$0.78
FCF per share	$0.49
Financing cash flow	$-8.5M
Free cash flow	$4.2M
Free cash flow minus SBC	$-1.7M
Gross profit	$33.6M
Income taxes	$92,000
Investing cash flow	$4.1M
Net borrowing	$-8.5M
Net cash flow	$880,000
Net income	$15.3M
Operating cash flow minus SBC	$-665,000
Operating income	$3.1M
Revenue	$44M
Stock-based compensation	$5.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-3.54
Book value per share	$0.32
Debt / EBITDA	4.66
Debt / equity	7.43
Debt / FCF	4.92
Goodwill	$7.3M
Interest coverage	0.89
Long-term assets	$13.4M
Long-term liabilities	$15.6M
Net cash (debt)	$-11.3M
Net cash / market cap	-22.21%
Net debt / EBITDA	2.66
Net debt / equity	4.07
Net debt / FCF	2.69
Piotroski F-Score	4
Property, plant and equipment	$3.2M
Shareholders' equity	$2.8M
Tangible book value	$-7.4M
Tangible book value per share	$-0.86
Total assets	$36.6M
Total cash	$9.4M
Total debt	$20.7M
Total liabilities	$33.8M
WACC	13.36%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.26
Current assets	$23.2M
Current liabilities	$18.2M
Current ratio	1.28
Inventory turnover	1.61
Net working capital	$1.3M
Quick ratio	0.84
Working capital	$5M
Working capital turnover	-4.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-26.84%
Dividend yield	0%
Shareholder yield	-26.84%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-91.21%
10Y return CAGR	-21.59%
10Y total return	-91.21%
150-day SMA	$9.81
15Y price change	-99.21%
15Y return CAGR	-27.58%
15Y total return	-99.21%
1D price change	1.37%
1M price change	23.03%
1M total return	23.03%
1W price change	15.6%
1W total return	15.6%
1Y price change	-79.51%
1Y return CAGR	-79.53%
1Y total return	-79.51%
20-day SMA	$5.37
200-day SMA	$13.28
3M price change	-3.89%
3M total return	-3.89%
3Y price change	5.42%
3Y return CAGR	1.78%
3Y total return	5.42%
50-day SMA	$4.87
50-day SMA vs 200-day SMA	50under200
52-week high	$36.20
52-week high date	2025-11-11
52-week low	$3.92
52-week low date	2026-09-11
5Y price change	-86.82%
5Y return CAGR	-33.33%
5Y total return	-86.82%
6M price change	-62.3%
6M total return	-62.3%
After-hours change	-0.51%
After-hours close	$5.93
After-hours price	$5.90
All-time high	$2,249.97
All-time high date	2009-11-12
All-time low	$0.04
All-time low date	2021-11-15
Average true range (ATR)	$0.37
Average volume	41.8K
Beta (1Y)	2.26
Beta (2Y)	1.47
Beta (5Y)	1.42
Change from 52-week high	-83.62%
Change from 52-week low	51.28%
Change from all-time high	-99.74%
Change from all-time low	15,713.33%
Change from open	-1.5%
Day's gap	2.91%
Dollar volume	$214,691
High price	$6.19
Low price	$5.78
Monthly RSI	35.6
Open price	$6.02
Position in 52-week range	36.59%
Premarket change	4.05%
Premarket close	$5.93
Premarket price	$6.17
Premarket volume	783
Previous close	$5.85
Price vs 150-day SMA	-39.56%
Price vs 20-day SMA	10.47%
Price vs 200-day SMA	-55.34%
Price vs 50-day SMA	21.79%
Relative volume	0.87
RSI	63.98
Sharpe ratio	-1.29
Sharpe ratio (3Y)	0.43
Sharpe ratio (5Y)	0.42
Sortino ratio	-1.56
Sortino ratio (3Y)	0.7
Sortino ratio (5Y)	0.76
Volume	36.2K
Weekly RSI	35.7
YTD price change	-80.13%
YTD total return	-80.13%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6.2M
Float percentage	71.91%
Shares change (QoQ)	0.12%
Shares change (YoY)	26.84%
Shares held by insiders	4.91%
Shares held by institutions	25.02%
Shares outstanding	8.6M
Short % of float	3.82%
Short % of shares	2.75%
Short ratio	4 days

Deeper analysis on SNWV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SNWV report

Is a complete SNWV research report available?

No complete published report is available for SANUWAVE Health, Inc. (SNWV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SANUWAVE Health, Inc. (SNWV)

Price

Financial snapshot

Fair-value bridge

Latest news · SNWV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNWV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SNWV

Frequently asked questions